About Biocartis
Biocartis is a company based in Mechelen (Belgium) founded in 2007.. Biocartis has raised $305.3 million across 18 funding rounds from investors including Philips, Johnson & Johnson and KBC Bank & Verzekering. Biocartis has completed 1 acquisition, including Pronota. Biocartis offers products and services including Idylla Platform, Oncology Tests, and Research Assays. Biocartis operates in a competitive market with competitors including Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others.
- Headquarter Mechelen, Belgium
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biocartis Nv
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biocartis
Biocartis offers a comprehensive portfolio of products and services, including Idylla Platform, Oncology Tests, and Research Assays. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Automated system for rapid molecular testing in oncology labs
Tests for detecting mutations in cancer biomarkers quickly
Assays for exploring new biomarkers in research settings
Unlock access to complete
Unlock access to complete
Leadership Team
7 people
Sales and Marketing
3 people
Product Management Team
3 people
Senior Team
3 people
Finance and Accounting
2 people
Legal and Compliance
2 people
Human Resources and Administration
2 people
Software Development Team
2 people
Unlock access to complete
Funding Insights of Biocartis
Biocartis has successfully raised a total of $305.3M across 18 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 18
- Last Round Last Round
-
First Round
First Round
(15 Oct 2009)
- Investors Count 19
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2022 | Amount | Post-IPO - Biocartis | Valuation |
investors |
|
| May, 2021 | Amount | Grant - Biocartis | Valuation |
investors |
|
| Dec, 2020 | Amount | Post-IPO - Biocartis | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biocartis
Biocartis has secured backing from 19 investors, including institutional and venture fund investors. Prominent investors backing the company include Philips, Johnson & Johnson and KBC Bank & Verzekering. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity is directed toward private and public companies.
|
Founded Year | Domain | Location | |
|
Venture capital firm backed by Johnson & Johnson
|
Founded Year | Domain | Location | |
|
Private debt funds are managed across multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biocartis
Biocartis has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Pronota. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Diagnostics for heart failure, pre-eclampsia, and sepsis are provided.
|
2004 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Biocartis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biocartis Comparisons
Competitors of Biocartis
Biocartis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
|
| domain | founded_year | HQ Location |
Adhesive patch biopsies for skin cancer detection are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biocartis
Frequently Asked Questions about Biocartis
When was Biocartis founded?
Biocartis was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Where is Biocartis located?
Biocartis is headquartered in Mechelen, Belgium. It is registered at Mechelen, Antwerp, Belgium.
Is Biocartis a funded company?
Biocartis is a funded company, having raised a total of $305.3M across 18 funding rounds to date. The company's 1st funding round was a Post-IPO of $181.8M, raised on Oct 15, 2009.
What does Biocartis do?
Biocartis was founded in 2007 in Mechelen, Belgium, within the molecular diagnostics sector. Proprietary micro-technology platforms are utilized for integrated molecular and immunodiagnostics. Multiplexed detection, quantification, and amplification of bio-analytes such as proteins, nucleic acids, and small molecules are enabled. Analysis of biomolecules linked to disease risk factors, early detection, staging, treatment selection, and monitoring is supported across various applications.
Who are the top competitors of Biocartis?
Biocartis's top competitors include Guardant Health, Foundation Medicine and Natera.
What products or services does Biocartis offer?
Biocartis offers Idylla Platform, Oncology Tests, and Research Assays.
How many acquisitions has Biocartis made?
Biocartis has made 1 acquisition, including Pronota.
Who are Biocartis's investors?
Biocartis has 19 investors. Key investors include Philips, Johnson & Johnson, KBC Bank & Verzekering, Debiopharm, and PMV.